Researchers at the Karlsruhe Institute of Technology (KIT) have reported important progress in quantum physics and materials ...

Why Michigan Mid-Market Employers Are Replacing Group Health Plans with ICHRA Bloomfield Hills, United States - April ...

Ingo Swann participated in classified experiments involving remote viewing. According to his account, he observed structures on the Moon. How Canada's 7th largest bank aims to go from unknown initials ...

The deadly mass shooting at a school in British Columbia came as Canadian authorities face significant obstacles in rolling out a nationwide firearms buyback that is mired in practical and logistical ...

An Arizona Supreme Court program allowing nonlawyers to own law firms has led to numerous consumer complaints. Several members of the program's oversight committee also have financial ties to firms ...

TRAVERSE CITY — Grand Traverse County commissioners want answers about the Chain of Lakes and the work that’s needed on the dams that control their levels. So they voted unanimously this week to seek ...

Fred Voccola, Chairman & CEO Simpro Group and the author of the book, The Coming Disruption: What It Takes to Lead in the AI-First Era. The org chart just died. Most leaders just haven’t noticed yet.

SALT LAKE CITY — Close to 60,000 structures across Utah are considered at "high risk" for being impacted by wildfires, putting some homeowners on the path to pay new fees, according to a new state map ...

Dubbed “The Great Flood of 2019” by The New York Times, the Lower Missouri River Basin experienced its third severe flood event over a 30-year period that ravaged communities and infrastructure across ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...